Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Invitrogen Corp.

Dec 2006
Invitrogen Corp. of Carlsbad, Calif., will acquire Phillipsburg, New Jersey-based Sentigen Holding Corp., a developer of bioassay systems, in a cash transaction valued at $3.37 a share, or approximately $25.9 million. With the purchase, the California company will expand its cellular assay capabilities.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!